Skip to main content

Table 1 Baseline characteristics of the trial groups participating in the study at offspring age of six years (mean or frequency and 95% confidence interval*)

From: A pragmatic controlled trial to prevent childhood obesity within a risk group at maternity and child health-care clinics: results up to six years of age (the VACOPP study)

 

Intervention

Control

p-value

Missing

N

71

76

  

Age of mother before pregnancy (years)

31.8 (30.4 to 33.1)

30.2 (29.0 to 31.5)

0.09a

Mother’s education

  

0.90c

 Low

29.6% (20.2% to 41.0%)

27.6% (18.8% to 38.6%)

  

 Medium

42.2% (31.5% to 53.8%)

46.1% (35.3% to 57.2%)

  

 High

28.2% (19.0% to 39.5%)

26.3% (17.7% to 37.2%)

  

Father’s education

  

0.30c

 Low

31.0% (21.4% to 42.5%)

35.5% (25.7% to 46.7%)

  

 Medium

35.2% (25.1% to 46.8%)

42.1% (31.6% to 53.3%)

  

 High

33.8% (23.9% to 45.4%)

22.4% (14.5% to 32.9%)

  

Mother’s pre-pregnancy BMI (kg/m2)

27.4 (26.3 to 28.5)

26.6 (25.6 to 27.5)

0.25a

Proportion of mothers with obesity (BMI ≥ 30 kg/m2)

23.9% (15.5% to 35.0%)

18.4% (11.3% to 28.6%)

0.41c

Father’s BMI (kg/m2)

26.9 (26.0 to 27.7)

27.1 (26.1 to 28.1)

0.69b

2, 3

Proportion of fathers with obesity (BMI ≥ 30 kg/m2)

17.4% (10.2% to 28.0%)

16.4% (9.7% to 26.6%)

0.88c

2, 3

Mother, type 2 diabetes

0.0% (0% to 5.2%)

1.3% (0.2% to 7.1%)

1.00d

1, 0

Father, type 2 diabetes

1.4% (0.3% to 7.8%)

1.4% (0.2% to 7.3%)

1.00d

2, 2

Proportion of grandparent with obesity (BMI ≥ 30 kg/m2)

52.3% (40.4% to 64.0%)

56.3% (44.8% to 67.3%)

0.38c

6, 5

Parity

  

0.28c

 Primiparous

59.2% (47.5% to 69.8%)

46.0% (35.3% to 57.2%)

  

 Second pregnancy

23.9% (15.5% to 35.0%)

32.9% (23.4% to 44.1%)

  

 At least third pregnancy

16.9% (9.9% to 27.3%)

21.1% (13.4% to 31.5%)

  

History of newborn > 4500 g

2.9% (0.8% to 9.8%)

3.9% (1.4% to 11.0%)

0.72c

1, 0

Mother smoking during pregnancy

1.4% (0.2% to 7.6%)

9.2% (4.5% to 17.8%)

0.04c

Mother’s physical activity (hours/week) during first trimester of pregnancy (before intervention)

4.5 (3.7 to 5.2)

4.5 (3.6 to 5.3)

0.38b

2, 3

OGTT (weeks 26–28 of gestation)

 Pathological OGTT result (0 h ≥ 5.3 or

    

 1 h ≥ 10.0 or 2 h ≥ 8.6 mmol/l)

23.9% (15.5% to 35.0%)

46.1% (35.3% to 57.2%)

0.01c

Gestational weight gain until 37 weeks (kg)

11.3 (10.2 to 12.4)

12.9 (11.6 to 14.3)

0.08a

2, 0

Neonatal outcomes

 Gestational age at birth

39.5 (39.1 to 39.9)

39.4 (39.1 to 39.7)

0.53b

 Sex of newborn (boy)

53.5% (42.0% to 64.6%)

52.6% (41.6% to 63.5%)

0.91c

 Birth weight (grams)

3455 (3333 to 3576)

3509 (3407 to 3611)

0.49a

 Large for gestational age

5.6% (2.2% to 13.6%)

6.6% (2.8% to 14.5%)

0.81c

 Exclusive breastfeeding (months)

3.2 (2.7 to 3.7)

2.7 (2.2 to 3.2)

0.16b

1, 0

  1. aIndependent-samples t-test. bMann–Whitney U-test. cChi-squared test. dFisher’s exact test
  2. *Wilson score method for interval without continuity correction
  3. BMI body mass index, OGTT oral glucose tolerance test (2-h)